Synergistic interaction and cumulative effect between frailty and triglyceride-glucose index exacerbate

Menglu Liu1, Jiawen Li1, Kailun Yan1

  • 1National Clinical Research Center for Cardiovascular Diseases, State Key Laboratory of Cardiovascular Disease, Fu Wai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.

Insights

Frailty and high triglyceride-glucose index (TyG) significantly increase cardiovascular disease (CVD) risk in aging adults. These factors act synergistically, with cumulative effects further intensifying the risk of developing CVD.

Area of Science:

  • Gerontology
  • Cardiovascular Medicine
  • Metabolic Health

Background:

  • Frailty and high triglyceride-glucose index (TyG) are independent risk factors for cardiovascular disease (CVD).
  • These conditions frequently coexist in middle-aged and older adults.
  • Understanding their combined impact is crucial for aging populations.

Purpose of the Study:

  • To investigate the synergistic influence of frailty and high TyG on incident CVD risk.
  • To explore the cumulative effects of frailty and TyG over time.
  • To provide insights into CVD prevention strategies for aging individuals.

Main Methods:

  • Analysis of data from the China Health and Retirement Longitudinal Study (CHARLS).
  • Assessment of frailty using the Rockwood frailty index.
  • Calculation of TyG index using fasting triglyceride and glucose levels.

Main Results:

  • Both frailty and high TyG independently elevated CVD risk over nine years.
  • Individuals with both frailty and high TyG exhibited the highest risk of incident CVD (aHR 2.53).
  • Cumulative effects showed the highest risk with upper cumulative frailty index and higher cumulative TyG (aHR 3.13).

Conclusions:

  • Frailty and high TyG synergistically increase the risk of incident CVD.
  • Cumulative effects of frailty and TyG intensify the association with CVD risk.
  • This highlights the importance of managing both frailty and metabolic factors for cardiovascular health in aging populations.
Abstract

Related Concept Videos

Overview of Lipid Metabolism01:24

Overview of Lipid Metabolism

Lipid metabolism is a crucial process in the human body that involves the synthesis and degradation of lipids. This process is essential for energy production, cell membrane formation, and hormone production, among other functions.
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
2.5K
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
67
Overview of Carbohydrate Metabolism01:19

Overview of Carbohydrate Metabolism

Carbohydrate metabolism is a fundamental biochemical process that ensures a constant supply of energy to living cells. The most important carbohydrate is glucose, which can be broken down via glycolysis to enter into the Krebs cycle and eventually lead to the production of ATP through oxidative phosphorylation.
Glucose transport into cells is facilitated by a family of transport proteins called GLUT (Glucose Transporters). GLUT4 is the primary glucose transporter for insulin-stimulated glucose...
1.9K
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
41
Obesity01:24

Obesity

The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
624
Cholesterol: Significance and Regulation01:29

Cholesterol: Significance and Regulation

Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...
697